Avoro Capital Advisors’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$97M	Hold	21,700,000	–	–	0.95%	20
2025 Q4	$119M	Hold	21,700,000	–	–	1.17%	21
2025 Q3	$71M	Hold	21,700,000	–	–	0.92%	22
2025 Q2	$50.1M	Buy	21,700,000 +1,700,001	+9%	+$3.69M	0.88%	22
2025 Q1	$27.8M	Hold	19,999,999	–	–	0.43%	28
2024 Q4	$34.6M	Buy	19,999,999 +1,349,999	+7%	+$2.8M	0.49%	28
2024 Q3	$37.5M	Hold	18,650,000	–	–	0.55%	29
2024 Q2	$41.8M	Hold	18,650,000	–	–	0.56%	31
2024 Q1	$53.5M	Buy	18,650,000 +14,294,445	+328%	+$29.8M	0.62%	30
2023 Q4	$7.71M	Buy	4,355,555 +430,555	+11%	+$858K	0.11%	41
2023 Q3	$12.4M	Buy	+3,925,000	New	+$7.33M	0.19%	37